IGF2 and synovial sarcoma: Insulin growth factor-1 receptor (IGF-1R) is involved in IGF-II signalling and down-regulation or inhibition of this receptor leads to increased numbers of apoptotic cells in SS18–SSX-transformed cells and SS cell lines [21].